We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Guidelines Recommend Statins at 40 for Diabetics

By HospiMedica International staff writers
Posted on 22 Apr 2013
New Canadian guidelines recommend all patients with diabetes should start taking statins when they turn 40 and blood pressure drugs when they turn 55, even if they have no other risk factors at the time. More...


The recommendations of the Canadian Diabetes Association (CDA; Toronto, ON, USA) were developed by an expert committee of 120 leading health professionals across Canada who identified, evaluated, and synthesized the latest scientific evidence, and then translated actionable recommendations for people living with diabetes and their healthcare team. Among the recommendations is that screening for type 2 diabetes should be performed every three years for all Canadians over 40 years of age, or earlier and more frequently in those with risk factors.

The guidelines also recommend that those over 30 who have had diabetes for at least 15 years should also start on statins, and suggest use of ACE inhibitors and angiotensin receptor blockers (ARBs) in those ages 55 and up. The CDA also recommends that the vast majority of people living with diabetes should be targeting an A1C of 7%. Additional recommendations include specific strategies for the prevention and management of type 2 diabetes in children and Aboriginal peoples, and new approaches for the delivery of integrated care and effective self-management of the disease.

“Each person’s experience with diabetes can be different and the best way to manage the disease involves addressing their unique needs and tailoring a treatment plan to best meet those needs,” said Jan Hux, MD, Chief Scientific Advisor for the CDA. “The new Guidelines allow healthcare professionals to determine the best early management and treatment path to help reduce the potential for serious complications down the road.”

“In Canada, only 13% of patients with type 2 diabetes achieves all three targets in glucose, blood pressure, and LDL cholesterol control,” said chair of the guideline committee Alice Cheng, MD, of St. Michael's Hospital (Toronto, Canada). “Clearly, there's still a care gap, and we needed to find ways to address it. That's where these guidelines come in.”

The new Guidelines encourage people living with diabetes to know their heart health ABCDES: A - A1C Under the new recommendations, people with an A1C level of 6.5% or greater will be diagnosed with diabetes and those with an A1C level of 6.0%-6.4% will be diagnosed with prediabetes. B - Blood pressure optimally controlled. C- Cholesterol in target range. D - Drugs - heart-protecting medications for the right patients. E - Exercise and other lifestyle measures. S - Stop Smoking

Related Links:
Canadian Diabetes Association


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.